本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aeglea BioTherapeutics, Inc.

12.01
0.0000
成交量:- -
成交額:50.26萬
市值:4,862.76萬
市盈率:-0.16
高:12.01
開:12.01
低:12.01
收:12.01
52周最高:39.00
52周最低:2.66
股本:404.89萬
流通股本:192.19萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-75.0117
每股收益(LYR):-24.8618
淨資產收益率:-281.41%
總資產收益率:-41.82%
市淨率:-0.20
市盈率(LYR):-0.48

資料載入中...

2023/12/29

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/22

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/29

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/24

重要事件披露

Form 8-K - Current report
2023/11/18

SEC問詢函

Form CORRESP - Correspondence
2023/11/16

SEC問詢函

Form CORRESP - Correspondence
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/10/27

SEC問詢函

Form CORRESP - Correspondence
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report